| Literature DB >> 19292989 |
Abstract
In contrast to the other botulinum toxin products Xeomin only contains the 150kD neurotoxin without complexing proteins which have no therapeutic function and don't influence the diffusion of the neurotoxin. In large clinical Phase III studies (blepharospasm and cervical dystonia) Xeomin showed the same efficacy and profile of adverse events as Botox. Whereas competing product must be stored refrigerated, Xeomin is stable for 3years at room temperature.Entities:
Mesh：
Substances：
Year: 2009 PMID： 19292989 DOI： 10.1016/j.toxicon.2009.03.010
Source DB: PubMed Journal: Toxicon ISSN： 0041-0101 Impact factor: 3.033